ArticlePediatric radiology2025
How consistent is the interpretation of renal scarring in pediatric patients using technetium-99m dimercaptosuccinic acid scintigraphy.
Article in Pediatric radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTechnetium-99m dimercaptosuccinic acid (DMSA) scintigraphy plays a critical role in pediatric imaging for detecting renal cortical scarring, which is essential for diagnosing and managing kidney damage in children. However, variability in observer interpretation poses challenges, potentially impacting clinical decision-making and outcomes.
objectiveThis study aims to assess intra- and inter-observer agreement in interpreting DMSA scans for detecting renal cortical scarring in pediatric patients, focusing on the presence, location, and percentage of kidney involvement. MATERIALS AND
methodsThis prospective study analyzed 220 pediatric patients with suspected renal scarring. Four experienced radiologists independently reviewed DMSA scans on two separate occasions, 3-4 weeks apart, using standardized assessment criteria. Intra-observer agreement was measured using Cohen's kappa, while inter-observer agreement was assessed using pairwise Cohen's kappa for categorical evaluations and Kendall's tau-b for the percentage of kidney involvement.
resultsStrong intra-observer agreement was observed across all four radiologists, with Cohen's kappa values for renal scarring stages ranging from 0.704 to 0.955. Observer-4 consistently showed the highest agreement across all metrics. Inter-observer agreement varied substantially depending on observer pairs. Pairs excluding Observer-2 demonstrated moderate to substantial agreement (kappa up to 0.8268 and Kendall's tau-b up to 0.7192), while pairs involving Observer-2 showed poor to slight agreement. Variability was particularly notable in assessing scarring severity and defect localization.
conclusionWhile intra-observer consistency in interpreting DMSA scans is high, inter-observer variability remains a concern, especially in evaluating the severity and location of renal scarring. These findings underscore the need for standardized protocols and targeted training to enhance diagnostic accuracy. Moreover, the development of validated datasets could support the advancement of machine learning models for automated, precise detection of renal scarring, ultimately improving diagnostic reliability and patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.